Baird Medical Investment (BDMD) said Wednesday that the US Food and Drug Administration has issued a Certificate to Foreign Government to Egyptian regulators, confirming the company's compliance with US medical device standards and enabling market entry into Egypt.
The company has also submitted regulatory registration applications for its microwave ablation technology in Egypt, Hong Kong, Thailand, Malaysia, Kazakhstan, Sri Lanka, and India, and expects timely approvals in these regions.
To support its international rollout, Baird Medical is collaborating with local healthcare institutions to build distribution networks and provide training on microwave ablation procedures.
Shares of Baird Medical were down nearly 4% in recent trading.
Price: 5.31, Change: -0.21, Percent Change: -3.80
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.